The Role of MIR9-2 in Shared Susceptibility of Psychiatric Disorders during Childhood: A Population-Based Birth Cohort Study

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Autores
TOVO-RODRIGUES, Luciana
QUINTE, Gabriela Callo
BRUM, Clarice Brinck
GHISLENI, Gabriele
BASTOS, Clarissa Ribeiro
OLIVEIRA, Isabel Oliveira de
BARROS, Fernando C.
BARROS, Aluisio J. D.
SANTOS, Ina S.
ROHDE, Luis A.
Citação
GENES, v.10, n.8, article ID 626, 11p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: It has been suggested that microRNAs (miRNAs; short non-protein-coding RNA molecules that mediate post-transcriptional regulation), including mir-9 and mir-34 families, are important for brain development. Current data suggest that mir-9 and mir-34 may have shared effects across psychiatric disorders. This study aims to explore the role of genetic polymorphisms in the MIR9-2 (rs4916723) and MIR34B/C (rs4938723) genes on the susceptibility of psychiatric disorders in children from the 2004 Pelotas Birth Cohort. Methods: Psychiatric disorders were assessed in 3585 individuals using Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), criteria through the application of standard semi-structured interviews (using the Development and Well-Being Assessment, DAWBA) at the six-years-of-age follow-up. The outcome was defined as the presence of any mental disorder. We also considered two broad groups of internalizing and externalizing disorders to further investigate the role of these variants in mental health. Results: We observed an association between rs4916723 (MIR9-2) and the presence of any psychiatric disorder (odds ratios (OR) = 0.820; 95% CI = 0.7130-0.944; p = 0.006) and a suggestive effect on internalizing disorders (OR = 0.830; 95% CI = 0.698-0.987; p = 0.035). rs4938723 (MIR34B/C) was not associated with any evaluated outcome. Conclusion: The study suggests that MIR9-2 may have an important role on a broad susceptibility for psychiatric disorders and may be important mainly for internalization problems.
Palavras-chave
mental health, genetics, microRNA, birth cohort
Referências
  1. Alieva AK, 2015, PARKINSONISM RELAT D, V21, P72, DOI 10.1016/j.parkreldis.2014.10.018
  2. Alural B, 2017, PROG NEURO-PSYCHOPH, V73, P87, DOI 10.1016/j.pnpbp.2016.03.010
  3. Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757
  4. Banerjee-Basu S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00205
  5. Camkurt MA, 2016, CLIN PSYCHOPHARM NEU, V14, P256, DOI 10.9758/cpn.2016.14.3.256
  6. Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8
  7. de Girolamo G, 2012, EPIDEMIOL PSYCH SCI, V21, P47, DOI 10.1017/S2045796011000746
  8. Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015
  9. Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7
  10. Domschke K, 2013, MOD TR PHARMACOPSYCH, V29, P24, DOI 10.1159/000351932
  11. Faraone SV, 2019, MOL PSYCHIATR, V24, P562, DOI 10.1038/s41380-018-0070-0
  12. Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
  13. Fleitlich-Bilyk B, 2004, J AM ACAD CHILD PSY, V43, P727, DOI 10.1097/01.chi.0000120021.14101.ca
  14. Forero DA, 2010, HUM MUTAT, V31, P1195, DOI 10.1002/humu.21344
  15. Garcia-Martinez I, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.151
  16. Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909
  17. Griffith JW, 2010, PSYCHOL MED, V40, P1125, DOI 10.1017/S0033291709991449
  18. Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8
  19. Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56
  20. Hettema JM, 2006, AM J PSYCHIAT, V163, P857, DOI 10.1176/appi.ajp.163.5.857
  21. Issler O, 2015, NAT REV NEUROSCI, V16, P201, DOI 10.1038/nrn3879
  22. Jauhari A, 2019, NEUROMOL MED, V21, P97, DOI 10.1007/s12017-019-08535-9
  23. Kendler KS, 2010, PSYCHOL MED, V40, P801, DOI 10.1017/S0033291709991140
  24. Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c
  25. Lee P. H., 2019, BIORXIV, DOI [10.1101/528117, DOI 10.1101/528117]
  26. Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711
  27. Li MF, 2018, SCIENCE, V362, P1264, DOI 10.1126/science.aat7615
  28. Lima-Costa MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09812
  29. Liu MZ, 2019, NAT GENET, V51, P237, DOI 10.1038/s41588-018-0307-5
  30. Matijasevich A, 2015, J AFFECT DISORDERS, V174, P424, DOI 10.1016/j.jad.2014.12.012
  31. Middeldorp C. M., 2006, BIOL BASIS PERSONALI, P251
  32. Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666
  33. Nagel M, 2018, NAT GENET, V50, P920, DOI 10.1038/s41588-018-0151-7
  34. Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27
  35. Petresco S, 2014, SOC PSYCH PSYCH EPID, V49, P975, DOI 10.1007/s00127-014-0826-z
  36. Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
  37. Sandin S, 2017, JAMA-J AM MED ASSOC, V318, P1182, DOI 10.1001/jama.2017.12141
  38. Santos IS, 2014, INT J EPIDEMIOL, V43, P1437, DOI 10.1093/ije/dyu144
  39. Santos IS, 2011, INT J EPIDEMIOL, V40, P1461, DOI 10.1093/ije/dyq130
  40. Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176
  41. Shaik MM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040174
  42. Shi S, 2014, J BIOL CHEM, V289, P13434, DOI 10.1074/jbc.M113.535203
  43. Sim SE, 2016, J NEUROSCI, V36, P8641, DOI 10.1523/JNEUROSCI.0630-16.2016
  44. Smith RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-571
  45. Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552
  46. Topol A, 2016, CELL REP, V15, P1024, DOI 10.1016/j.celrep.2016.03.090
  47. Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460
  48. Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917
  49. Xu C, 2017, NEUROSCI LETT, V651, P65, DOI 10.1016/j.neulet.2017.04.061
  50. Zaits MN, 2014, MOL PSYCHIATR, V19, P848, DOI 10.1038/mp.2013.93
  51. Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576